Tina Runk

Ms. Runk has over 35 years of experience in research, preclinical & clinical development and operations, working with biopharmaceutical companies and CROs in the US and around the world, such as Oread, ILEX Oncology (Genzyme), PSI & Ergomed. She was instrumental in performing due diligence and acquiring AR-67, a major asset for Vivacitas Oncology.

Her strengths lie in quick and accurate assessment of needs analysis and efficient implementation to maximize productivity while staying under budget. She earned her BS in Biology and BA in Psychology from SUNY at Albany and her MBA from the University of Phoenix.

Speaker Details
Events of the Speaker
You might also love these events.
Meridian Clinical Trials - Presentation
November 22, 2021
5th Meridian Clinical Trials is a nexus of the clinical trials industry for networking, knowledge sharing, collaboration, and partner outreach. MCT partners with leading research institutions, private pharma-biotechs, and contract research organizations to stay updated about the latest scientific knowledge, research, and technology.
Upcoming